Latest News

Celgene, following BMS buyout, forms two immuno-oncology partnerships





The company said Friday morning that it would partner with two companies, Kyn Therapeutics and Obsidian Therapeutics.

Source link




Related posts

Women's Longevity, Old-Age Health Could Be Predicted By Mothers' Lifespan

Newsemia

Scientists closer to unraveling mechanisms of speech processing in the brain

Newsemia

Should we rename low risk cancers?

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy